Posted by Michael Wonder on 03 Jul 2023
Nevakar Injectables announces FDA approval of cyclophosphamide RTD solution
3 July 2023 - Ready to dilute, multi-dose vials reduce compounding time and waste.
Nevakar Injectables announced today that the US FDA has approved its new drug application for cyclophosphamide injection, 200mg/mL vials for use in combination therapy for various types of cancers, including malignant lymphoma, multiple myeloma, and various types of leukaemia.
